Advanced Colloidal Particle Formulation Reactor Tech
Legal Citation
Background and Problem Solved
The original patent disclosed a composite colloidal particle formulation with advanced functionality, comprising an engineered biodegradable particle core dispersed in a bioadhesive polyelectrolyte solution. However, the original patent had limitations in terms of scalability, stability, and manufacturing cost. This new invention addresses these limitations by introducing a modular, continuous-flow reactor for efficient mixing, a downstream processing unit for concentrating the formulation, and other innovations that enhance the overall efficiency and effectiveness of the formulation.
Novelty and Inventive Step
The new claims introduce novel and non-obvious improvements to the original patent, including the use of a modular, continuous-flow reactor, the addition of a secondary polyelectrolyte solution, the use of a cross-linking agent, real-time monitoring of formulation production, and the substitution of a low-cost, biorenewable anti-solvent. These innovations provide significant enhancements to the scalability, stability, and cost-effectiveness of the colloidal particle formulations.
Alternative Embodiments and Variations
Alternative embodiments of the invention could include the use of different reactor designs, varying the composition of the polyelectrolyte solution, or incorporating additional functional agents to enhance the formulation's properties. Variations of the invention could also include adapting the system for real-time monitoring to different types of particle formulations or integrating the system with existing manufacturing infrastructure.
Potential Commercial Applications and Market
The invention has significant commercial potential in various industries, including pharmaceuticals, biotechnology, cosmetics, and food processing, where scalable, efficient, and cost-effective production of advanced colloidal particle formulations is crucial. The invention's ability to enhance the stability, bioadhesive properties, and manufacturing efficiency of these formulations could lead to widespread adoption and significant market impact.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A01 | A01N25/22 |
| A | A01 | A01N25/04 |
| A | A01 | A01N25/10 |
| A | A01 | A01N59/20 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Colloidal particle formulation technologies, specifically biodegradable particle engineering and polyelectrolyte processing, with expertise in chemical engineering, materials science, and pharmaceutical formulation techniques
Person of Ordinary Skill (PHOSITA) Profile
A chemical engineer or materials scientist with advanced degree, experienced in particle engineering, familiar with solvent-antisolvent precipitation techniques, polyelectrolyte interactions, and scalable manufacturing processes
Obviousness Rationale
A PHOSITA would recognize that the PTD's variations represent predictable engineering improvements to the source patent's core colloidal particle formulation methodology. The disclosed modifications leverage standard techniques in particle engineering and manufacturing optimization that would be readily apparent to someone skilled in the art. The variations represent incremental enhancements that apply known strategies for improving particle production, stability, and cost-effectiveness.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,856,948 |
|---|---|
| Title | Colloidal particle formulations with advanced functionality |
| Assignee(s) | BENANOVA INC. |